Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study

Journal of Human Hypertension volume 30, pages 449–455 (2016)Cite this article

Subjects

Abstract

Measures of small and large artery dysfunction have not been investigated in a single cohort for the prediction of cardiovascular (CV) events in patients with nondialysed (ND) chronic kidney disease (CKD). This prospective cohort study aimed to determine whether central pulse wave velocity (cPWV), central pulse pressure (CPP) or microvascular post-occlusive reactive hyperaemia area (PORHHA) independently predict CV events and mortality in CKD-ND. A total of 94 stage 1–5 CKD-ND (65.3±13.1 years; estimated glomerular filtration rate 35.3 (22.8–49.4) ml min−1 per 1.73 m2) patients were followed-up for a median of 52 (36–65) months and had baseline cPWV and CPP measured by applanation tonometry and PORHHA by laser Doppler flowmetry. Multiple failure time Cox regression models were used to determine the predictive role of vascular parameters on CV mortality and events. Based on multiple linear regressions, baseline age, diabetes, CV disease, and systolic blood pressure (SBP) were independently related to cPWV (R2=0.3), SBP and PORHHA to CPP (R2=0.45), whereas CPP was the only parameter independently related to PORHHA (R2=0.16, all P<0.05). During follow-up, 41 CV events occurred (14 CV deaths). In univariate analyses, cPWV (1.07 (1.02–1.13) per m s−1), CPP (1.04 (1.01–1.07) per mm Hg) and lnPORHHA (0.70 (0.58–0.85) per ln(PU × s)) were all related to the outcome. Baseline diabetes (HR 3.07 (1.65–5.68)), lnFGF23 (fibroblast growth factor-23; 1.86 (1.13–3.06) per RU ml−1) and CPP (1.04 (1.01–1.07) per mm Hg) were independent predictors of CV events. The impaired pulsatile component of large arteries (CPP) independently of other vascular markers (cPWV, PORHHA) predicted CV outcomes in CKD-ND. CPP may integrate the information provided by cPWV and PORHHA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Schriffin EL, Lipman ML, Mann JF . Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85–97.

    Article  Google Scholar 

  2. Foley RN, Parfrey PS, Sarnak MJ . Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998; 32: S112–S119.

    Article  CAS  Google Scholar 

  3. Eknoyan G, Lameire N, Eckardt KU, Kasiske BL, Wheeler DC, Abboud OI et alKidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2013 (Suppl 3): S1–S150.

  4. de Jager DJ, Vervloet MG, Dekker FW . Noncardiovascular mortality in CKD: an epidemiological perspective. Nat Rev Nephrol 2014; 10 (4): 208–214.

    Article  CAS  Google Scholar 

  5. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39 (3): 735–738.

    Article  CAS  Google Scholar 

  6. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM . Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99 (18): 2434–2439.

    Article  CAS  Google Scholar 

  7. Sakuragi S, Abhayaratna WP . Arterial stiffness: methods of measurement, physiologic determinants and prediction of cardiovascular outcomes. Int J Cardiol 2010; 138 (2): 112–128.

    Article  Google Scholar 

  8. Sengstock D, Sands RL, Gillespie BW, Zhang X, Kiser M, Eisele G . Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease. Nephrol Dial Transplant 2010; 25 (3): 853–861.

    Article  Google Scholar 

  9. Townsend RR, Chirinos JA, Parsa A, Weir MA, Sozio SM, Lash JP et alChronic Renal Insufficiency Cohort Investigators. Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension 2010; 56 (3): 518–524.

    Article  CAS  Google Scholar 

  10. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63 (7): 636–646.

    Article  Google Scholar 

  11. Baumann M, Wassertheurer S, Suttmann Y, Burkhardt K, Heemann U . Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2-4. J Hypertens 2014; 32: 899–903.

    CAS  PubMed  Google Scholar 

  12. Quiroga B, Verdalles Ú, Reque J, García de Vinuesa S, Goicoechea M, Luño J . Cardiovascular events and mortality in chronic kidney disease (stages I-IV). Nefrologia 2013; 33 (4): 539–545.

    PubMed  Google Scholar 

  13. Kruger A, Stewart J, Sahityani R, O’Riordan E, Thompson C, Adler S et al. Laser Doppler flowmetry detection of endothelial dysfunction in endstage renal disease patients: correlation with cardiovascular risk. Kidney Int 2006; 70: 157–164.

    Article  CAS  Google Scholar 

  14. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et alThe Task Force for the Management of Arterial Hypertension of the European Society of Hypertension. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; (12): 1462–1536.

  15. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50: 197–203.

    Article  CAS  Google Scholar 

  16. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Abridged version of the expert consensus document on arterial stiffness. Artery Res 2007; 1: 2–12.

    Article  Google Scholar 

  17. Salvi P, Lio G, Labat C, Ricci E, Pannier B, Benetos A . Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device. J Hypertens 2004; 22 (12): 2285–2293.

    Article  CAS  Google Scholar 

  18. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T et alEuropean Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens 2012; 30 (3): 445–448.

    Article  CAS  Google Scholar 

  19. Farkas K, Nemcsik J, Kolossváry E, Járai Z, Nádory E, Farsang C et al. Impairment of skin microvascular reactivity in hypertension and uraemia. Nephrol Dial Transplant 2005; 20 (9): 1821–1827.

    Article  Google Scholar 

  20. Stiefel P, Moreno-Luna R, Vallejo-Vaz AJ, Beltrán LM, Costa A, Gómez L et al. Which parameter is better to define endothelial dysfunction in a test of postocclusive hyperemia measured by Laser-Doppler flowmetry? Coron Artery Dis 2012; 23: 57–61.

    Article  Google Scholar 

  21. Kubli S, Waeber B, Dalle-Ave A, Feihl F . Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiovasc Pharmacol 2000; 36 (5): 640–648.

    Article  CAS  Google Scholar 

  22. Prasad N, Sinha A . Clinical queries: malnutrition and co-morbidity in diabetic kidney disease patients. Nephrology 2012; 1: 138–143.

    Google Scholar 

  23. Huang Y, Gou R, Diao Y, Yin Q, Fan W, Liang Y et al. Charlson comorbidity index helps predict the risk of mortality for patients with type 2 diabetic nephropathy. J Zhejiang Univ Sci B 2014; 15 (1): 58–66.

    Article  CAS  Google Scholar 

  24. Lieb W, Larson MG, Benjamin EJ, Yin X, Tofler GH, Selhub J et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study. Circulation 2009; 119 (1): 37–43.

    Article  Google Scholar 

  25. Roman MJ, Devereux RB, Krzer JR, Okin PM, Lee ET, Wang WN et al. High central pulse pressure is independently associated with adverse cardiovascular outcome: the strong heart study. J Am Coll Cardiol 2009; 54: 1730–1734.

    Article  Google Scholar 

  26. van Sloten TT, Schram MT, van den Hurk K, Dekker JM, Nijpels G, Henry RM et al. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol 2014; 63 (17): 1739–1747.

    Article  Google Scholar 

  27. Vlachopoulos C, Aznaouridis K, Stefanidis C . Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55 (13): 1318–1327.

    Article  Google Scholar 

  28. Taal MW, Sigrist MK, Fakis A, Fluck RJ, McIntyre CW . Markers of arterial stiffness are risk factors for progression to end stage renal disease among patinets with chronic kidney disease stage 4 and 5. Nephron Clin Prac 2007; 107: c177–c181.

    Article  Google Scholar 

  29. Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C et alNephrotest Study Group. Arterial remodeling associates with CKD progression. J Am Soc Nephrol 2011; 22 (5): 967–974.

    Article  CAS  Google Scholar 

  30. Rossi M, Matteucci E, Pesce M, Consani C, Franzoni F, Santoro G et al. Peripheral microvascular dysfunction as an independent predictor of atherosclerotic damage in type 1 diabetes patients: a preliminary study. Clin Hemorheol Microcirc 2013; 54 (4): 381–391.

    CAS  PubMed  Google Scholar 

  31. Feihl F, Liaudet L, Waeber B . The macrocirculation and microcirculation of hypertension. Curr Hypertens Rep 2009; 11 (3): 182–189.

    Article  Google Scholar 

  32. Safar ME, Jankowski P . Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci 2009; 116: 273–282.

    Article  Google Scholar 

  33. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG . Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106 (16): 2085–2090.

    Article  Google Scholar 

  34. Xiao Y, Luo X, Huang W, Zhang J, Peng C . FGF 23 and risk of all-cause mortality and cardiovascular events: A meta-analysis of prospective cohort studies. Int J Cardiol 2014; 174 (3): 824–828.

    Article  Google Scholar 

  35. Turner J, Belch JJF, Khan F . Current concepts in assessment of microvascular endothelial function using laser doppler imaging and iontophoresis. Trends Cardiovasc Med 2008; 18: 109–116.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by research grants from the Hungarian Kidney Foundation, Hungarian Society of Hypertension and Hungarian Society of Nephrology.

Author information

Author notes

  1. O Cseprekál and J Egresits: These authors contributed equally to this work.

Authors and Affiliations

  1. First Department of Internal Medicine, Semmelweis University, Budapest, Hungary

    O Cseprekál, J Egresits, Á Tabák, Z Nemcsik-Bencze & A Tislér

  2. Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany

    J Egresits

  3. Department of Family Medicine, Semmelweis University, Budapest, Hungary

    J Nemcsik

  4. Department of Emergency Medicine, Uzsoki Hospital, Budapest, Hungary

    J Nemcsik

  5. Department of Cardiology, St Imre University Teaching Hospital, Budapest, Hungary

    Z Járai, L Babos, G Godina & L Sallai

  6. Department of Nephrology and Hypertension, St Imre University Teaching Hospital, Budapest, Hungary

    E Fodor, L Kerkovits & I Kiss

  7. Angiology Division, St Imre University Teaching Hospital, Budapest, Hungary

    K Farkas

  8. Second Department of Internal Medicine, Semmelweis University, Budapest, Hungary

    K I Kárpáthi

  9. Nephrology Division, Uzsoki Teaching Hospital, Budapest, Hungary

    A Marton & Z Németh

  10. Department of Radiology and Oncology, Semmelweis University, Budapest, Hungary

    Z Nemcsik-Bencze

Authors
  1. O Cseprekál
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Egresits
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Á Tabák
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Nemcsik
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Z Járai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Babos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E Fodor
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K Farkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G Godina
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K I Kárpáthi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. L Kerkovits
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Marton
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Z Nemcsik-Bencze
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Z Németh
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. L Sallai
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. I Kiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. A Tislér
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O Cseprekál.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Journal of Human Hypertension website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cseprekál, O., Egresits, J., Tabák, Á. et al. The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study. J Hum Hypertens 30, 449–455 (2016). https://doi.org/10.1038/jhh.2015.96

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2015.96

Search

Advanced search

Quick links